![Lesinurad Sodium - CAS# 1151516-14-1 MXAA) 5S)-5-ethyl-6-methylhept-3-en-2-yl]-9a](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M8522_1621503735.gif?v=1742822195)
Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
5S)-5-ethyl-6-methylhept-3-en-2-yl]-9a
is a selective BMP type I receptor inhibitor
BMS-345541 is also found to override the spindle checkpoint in nocodazole-arrested cells
DAG lipase) with IC50 of 4 μM for cholinesterase activity
In neuroblastoma (NB) cell lines
Lesinurad Sodium - CAS# 1151516-14-1 MXAA) 5S)-5-ethyl-6-methylhept-3-en-2-yl]-9aLesinurad, also known as RDEA594, is a selective uric acid re absorption inhibitor (SURI) and is also a selective inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body. RDEA594 has been shown to normalize the amount of uric acid excreted by gout patients previously classified as under excretors. Lesinurad received FDA approval on December 22, 2015. Product information CAS Number: 1151516 14 1 Molecular